Utama › Sklerosis Pelbagai › Wisconsin
Kajian klinikal Sklerosis Pelbagai di Wisconsin
7 kajian untuk Sklerosis Pelbagai sedang mencari peserta di lokasi di Wisconsin.
Bandar di Wisconsin
Teks kajian rasmi (Bahasa Inggeris)
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Greenfield
- TG Therapeutics Investigational Trial Site, Milwaukee
- TG Therapeutics Investigational Trial Site, Neenah
- dan 1 lagi
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06433752RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Wisconsin at Madison, Madison
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07002034Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Medical College of Wisconsin, Milwaukee
Mengambil pesertaFasa 3
Umur 10 hingga 17 · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06408259A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Milwaukee
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06680037An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
- Research Site, Milwaukee
Mengambil pesertaFasa 1
Umur 18 hingga 60 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT07224373Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
- Brain Inflammation Collaborative, Delafield
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 2 ke atas · Semua jantina · Dikemas kini 22 Jan 2026 · NCT04806620High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis
- Marquette University, Milwaukee
Mengambil peserta
Umur 18 hingga 75 · Semua jantina · Dikemas kini 5 Jun 2024 · NCT05735691Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.